Wood Group wins multi-million dollar contract with Glaxo in Germany

Wood Group has won a multi-million dollar contract to support GlaxoSmithKline in Germany.

The company will provide GSK Vaccines with engineering, procurement and construction management services for a new biotech facility to be built in Marburg. The contract includes detailed design, procurement and subcontracting services, expediting and inspection of process equipment and packages, construction management, coordination of commissioning, engineering follow-up during construction, design qualification, as well as the overall project management.

Wood Group's Environment & Infrastructure Solutions business has already completed outline design for the facility, which will produce bulk recombinant proteins used in meningitis vaccines. Completion of commissioning is scheduled for July 2019.

Chief executive Robin Watson said: "This new contract recognises GSK’s confidence in our global capabilities and broad, innovative solutions, based on our strong track record of supporting them for over a decade in locations including Singapore, Belgium, Italy, France and Hungary.

“Our focus is applying our vast knowledge and expertise in designing and constructing vaccines facilities, to ensure the safe and efficient delivery of this significant project in Germany. We look forward to working in partnership with GSK on this contract, which is another significant step towards delivering our growth ambitions in the pharmaceuticals sector.”

Wood said the contract builds on its 12-year relationship supporting GSK Vaccines across its global portfolio and is the second to be awarded under a five-year master agreement.